Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 10, 2006
p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas
S E Anderson, D Nonaka, S Chuai, et al.
Gynecologic Oncology
|
March 30, 2001
Complications associated with intraperitoneal chemotherapy catheters
S Makhija, M Leitao, P Sabbatini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset
D O Hardy, H I Scher, T Bogenreider, et al.
Gynecologic Oncology
|
May 24, 2001
Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer
M L Hensley, D Lebeau, L F Leon, et al.
Gynecologic Oncology
|
March 30, 1999
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
A Husain, P Sabbatini, D Spriggs, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2006
Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?
J Dupont, C Aghajanian, G Andrea, et al.
European Journal of Gynaecological Oncology
|
January 1, 2009
A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission
M Juretzka, M L Hensley, W Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 16, 2007
Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy
P Sabbatini, D Mooney, A Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 17, 2007
A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer
A L Leiser, F C Maluf, D S Chi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer
F C Maluf, A L Leiser, C Aghajanian, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 10, 2006
p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas
S E Anderson, D Nonaka, S Chuai, et al.
Gynecologic Oncology
|
March 30, 2001
Complications associated with intraperitoneal chemotherapy catheters
S Makhija, M Leitao, P Sabbatini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset
D O Hardy, H I Scher, T Bogenreider, et al.
Gynecologic Oncology
|
May 24, 2001
Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer
M L Hensley, D Lebeau, L F Leon, et al.
Gynecologic Oncology
|
March 30, 1999
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
A Husain, P Sabbatini, D Spriggs, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2006
Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?
J Dupont, C Aghajanian, G Andrea, et al.
European Journal of Gynaecological Oncology
|
January 1, 2009
A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission
M Juretzka, M L Hensley, W Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 16, 2007
Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy
P Sabbatini, D Mooney, A Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 17, 2007
A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer
A L Leiser, F C Maluf, D S Chi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer
F C Maluf, A L Leiser, C Aghajanian, et al.
Page
of 5